Type 2 diabetes and polycystic ovary syndrome

被引：19
|
作者：
Legro, Richard S. [1 ]
机构：
[1] Penn State Univ, Coll Med, MS Hershey Med Ctr, Dept Obstet & Gynecol, Hershey, PA 17033 USA
来源：
FERTILITY AND STERILITY | 2006年 / 86卷
关键词：
polycystic ovary syndrome; hyperandrogenism; insulin resistance; diabetes; anovulation;
D O I：
10.1016/j.fertnstert.2006.04.010
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
Women with polycystic ovary. syndrome (PCOS) have multiple factors that contribute to increased diabetes risk, including: insulin resistance, beta-cell dysfunction, obesity, especially centripetal obesity, family history of type 2 diabetes, and personal history of gestational-diabetes. Additionally there is some evidence to suggest that polycystic ovaries and chronic anovulation per se are risk factors. Identifying glucose intolerance and treating it are important aspects of the, care for women with PCOS.
引用
收藏
页码：S16 / S17
页数：2
相关论文
共 50 条
  • [41] Prevalence, pathogenesis and management of prediabetes and type 2 diabetes mellitus in patients with polycystic ovary syndrome
    Sofia Lazaridou
    Konstantinos Dinas
    Konstantinos Tziomalos
    Hormones, 2017, 16 : 373 - 380
  • [42] Development and Risk Factors of Type 2 Diabetes in a Nationwide Population of Women With Polycystic Ovary Syndrome
    Rubin, Katrine Hass
    Glintborg, Dorte
    Nybo, Mads
    Abrahamsen, Bo
    Andersen, Marianne
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2017, 102 (10): : 3848 - 3857
  • [43] Type 2 diabetes susceptibility single-nucleotide polymorphisms are not associated with polycystic ovary syndrome
    Ewens, Kathryn G.
    Jones, Michelle R.
    Ankener, Wendy
    Stewart, Douglas R.
    Urbanek, Margrit
    Dunaif, Andrea
    Legro, Richard S.
    Chua, Angela
    Azziz, Ricardo
    Spielman, Richard S.
    Goodarzi, Mark O.
    Strauss, Jerome F., III
    FERTILITY AND STERILITY, 2011, 95 (08) : 2538 - U566
  • [44] Association of biochemical hyperandrogenism with type 2 diabetes and obesity in Chinese women with polycystic ovary syndrome
    Zhao, Xiaomiao
    Zhong, Junmin
    Mo, Yaqin
    Chen, Xiaoli
    Chen, Yaxiao
    Yang, Dongzi
    INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 2010, 108 (02) : 148 - 151
  • [45] Complex diseases and co-morbidities: polycystic ovary syndrome and type 2 diabetes mellitus
    Rodgers, Raymond J.
    Avery, Jodie C.
    Moore, Vivienne M.
    Davies, Michael J.
    Azziz, Ricardo
    Stener-Victorin, Elisabet
    Moran, Lisa J.
    Robertson, Sarah A.
    Stepto, Nigel K.
    Norman, Robert J.
    Teede, Helena J.
    ENDOCRINE CONNECTIONS, 2019, 8 (03): : R71 - R75
  • [46] Prevalence, pathogenesis and management of prediabetes and type 2 diabetes mellitus in patients with polycystic ovary syndrome
    Lazaridou, Sofia
    Dinas, Konstantinos
    Tziomalos, Konstantinos
    HORMONES-INTERNATIONAL JOURNAL OF ENDOCRINOLOGY AND METABOLISM, 2017, 16 (04): : 373 - 380
  • [47] Risk of Type 2 Diabetes, MASLD and Cardiovascular Disease in People Living With Polycystic Ovary Syndrome
    Henney, Alex E.
    Gillespiec, Conor S.
    Lai, Jonathan Y. M.
    Schofield, Pieta
    Riley, David R.
    Caleyachetty, Rishi
    Barber, Thomas M.
    Miras, Alexander D.
    Dobbie, Laurence J.
    Hughes, David M.
    Alam, Uazman
    Hydes, Theresa J.
    Cuthbertson, Daniel J.
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2024,
  • [48] Type 2 diabetes and cardiovascular disease in polycystic ovary syndrome: what are the risks and can they be reduced?
    Tomlinson, J.
    Millward, A.
    Stenhouse, E.
    Pinkney, J.
    DIABETIC MEDICINE, 2010, 27 (05) : 498 - 515
  • [49] Polycystic ovary syndrome as a diabetes risk factor
    Moghetti, Paolo
    Tosi, Flavia
    EXPERT REVIEW OF ENDOCRINOLOGY & METABOLISM, 2013, 8 (06) : 485 - 487
  • [50] Screening for diabetes in women with polycystic ovary syndrome
    Lau, David C. W.
    CANADIAN MEDICAL ASSOCIATION JOURNAL, 2007, 176 (07) : 951 - 952
12345